Draft genome sequence of an aminoglycoside-resistant RmtG-producing Pseudomonas aeruginosa ST235 isolated from a cystic fibrosis patient

J Glob Antimicrob Resist. 2017 Mar:8:106-107. doi: 10.1016/j.jgar.2016.11.005. Epub 2017 Jan 7.

Abstract

Cystic fibrosis (CF) patients are often chronically colonised or infected by non-fermenting Gram-negative bacilli, with Pseudomonas aeruginosa being the most prevalent. In this study, we report the draft genome sequence of a multidrug-resistant P. aeruginosa strain belonging to sequence type ST235, isolated from the respiratory tract of a CF patient with chronic colonisation. Whole-genome sequencing analysis revealed a 6.7Mb genome size and the presence of 12 antibiotic resistance genes, including the rmtG gene conferring high-level aminoglycoside resistance, located on the chromosome.

Keywords: Brazil; Cystic fibrosis; Pseudomonas aeruginosa; RmtG; WGS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aminoglycosides / pharmacology
  • Anti-Bacterial Agents / pharmacology
  • Cystic Fibrosis / complications
  • Drug Resistance, Bacterial
  • Genes, Bacterial
  • Genome, Bacterial*
  • Humans
  • Pseudomonas Infections / microbiology
  • Pseudomonas aeruginosa / drug effects
  • Pseudomonas aeruginosa / genetics*
  • Pseudomonas aeruginosa / isolation & purification
  • Sequence Analysis, DNA*
  • Whole Genome Sequencing*

Substances

  • Aminoglycosides
  • Anti-Bacterial Agents